Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA 19111.
Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA 19111
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6818-6827. doi: 10.1073/pnas.1814279116. Epub 2019 Mar 13.
Targeting protein kinases is an important strategy for intervention in cancer. Inhibitors are directed at the active conformation or a variety of inactive conformations. While attempts have been made to classify these conformations, a structurally rigorous catalog of states has not been achieved. The kinase activation loop is crucial for catalysis and begins with the conserved DFGmotif. This motif is observed in two major classes of conformations, DFGin-a set of active and inactive conformations where the Phe residue is in contact with the C-helix of the N-terminal lobe-and DFGout-an inactive form where Phe occupies the ATP site exposing the C-helix pocket. We have developed a clustering of kinase conformations based on the location of the Phe side chain (DFGin, DFGout, and DFGinter or intermediate) and the backbone dihedral angles of the sequence X-D-F, where X is the residue before the DFGmotif, and the DFG-Phe side-chain rotamer, utilizing a density-based clustering algorithm. We have identified eight distinct conformations and labeled them based on the Ramachandran regions (A, alpha; B, beta; L, left) of the XDF motif and the Phe rotamer (minus, plus, trans). Our clustering divides the DFGin group into six clusters including BLAminus, which contains active structures, and two common inactive forms, BLBplus and ABAminus. DFGout structures are predominantly in the BBAminus conformation, which is essentially required for binding type II inhibitors. The inactive conformations have specific features that make them unable to bind ATP, magnesium, and/or substrates. Our structurally intuitive nomenclature will aid in understanding the conformational dynamics of kinases and structure-based development of kinase drugs.
靶向蛋白激酶是干预癌症的重要策略。抑制剂针对的是活性构象或多种非活性构象。虽然已经尝试对这些构象进行分类,但尚未实现具有结构严谨性的状态目录。激酶激活环对于催化至关重要,它始于保守的 DFG 基序。该基序存在于两种主要构象类别中,DFGin-一组活性和非活性构象,其中 Phe 残基与 N 端结构域的 C 螺旋接触-和 DFGout-一种非活性形式,其中 Phe 占据 ATP 结合位点,暴露出 C 螺旋口袋。我们已经开发了一种基于 Phe 侧链位置(DFGin、DFGout 和 DFGinter 或中间)和序列 X-D-F 的骨架二面角的激酶构象聚类,其中 X 是 DFG 基序之前的残基,DFG-Phe 侧链构象是利用基于密度的聚类算法。我们已经确定了八个不同的构象,并根据 XDF 基序和 Phe 侧链构象(减,加,转)的 Ramachandran 区域(A,alpha;B,beta;L,left)对它们进行了标记。我们的聚类将 DFGin 组分为六个簇,包括包含活性结构的 BLAminus,以及两种常见的非活性形式 BLBplus 和 ABAminus。DFGout 结构主要处于 BBAminus 构象,这对于结合 II 型抑制剂是必需的。非活性构象具有特定的特征,使其无法结合 ATP、镁和/或底物。我们直观的结构命名法将有助于理解激酶的构象动力学和基于结构的激酶药物开发。